Letters Urinary testing for HPV

Authors’ reply to Vorsters and colleagues

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6253 (Published 15 October 2014) Cite this as: BMJ 2014;349:g6253
  1. Neha Pathak, academic foundation year 2 doctor1,
  2. Julie Dodds, senior clinical trials manager1,
  3. Javier Zamora, senior lecturer in perinatal statistics12,
  4. Khalid Khan, professor of women’s health and clinical epidemiology1
  1. 1Women’s Health Research Unit, Centre for Primary Care and Public Health, Blizard Institute, Barts and the London School of Medicine and Dentistry, London E1 2AB, UK
  2. 2Clinical Biostatistics Unit, Hospital Ramon y Cajal (IRYCIS) and CIBER Epidemiologia y Salud Publica, Madrid, Spain
  1. javier.zamora{at}hrc.es

We thank Vorsters and colleagues for their insightful comments on our paper.1 2 We agree with Vorsters and colleagues and the editorialists that further research is needed to evaluate the impact of urine sampling procedures and testing protocols for the detection of HPV in urine.3 …

View Full Text

Log in

Log in through your institution


* For online subscription